Proteogenomic analysis of 5,411 plasma proteins in sickle cell disease patients

There are few therapeutic options to treat patients with sickle cell disease (SCD), a blood disorder caused by mutations in the β-globin gene that affects > 7M individuals worldwide. Combining human genetics and high-throughput proteomics can help identify new drug targets. Here, we present results from a proteogenomic analysis of the plasma proteome in SCD patients. We measured the levels of 5,411 plasma proteins and tested their associations with common genetic variation in 343 SCD patients. After conditional analyses, we identified 560 protein quantitative trait loci (pQTL), including 58 (10%) that are novel. Many of these pQTL are not specific to SCD patients and associate with clinically relevant traits in non-SCD African Americans from the Million Veteran Program (e.g., hemoglobin concentration, triglycerides). The effect sizes of the pQTL are largely concordant between SCD and non-SCD individuals, although we found examples (e.g., APOL1, haptoglobin) with evidence of heterogeneity that suggests an interaction between the plasma proteome and the SCD genotype. Finally, we combine pQTL and genome-wide association study results for fetal hemoglobin (HbF) in a Mendelian randomization analysis to prioritize four proteins that may increase HbF production (ENPP5, LBP, PTX3, ZP3). We have combined high-throughput DNA genotyping and plasma proteome profiling to confirm known and identify new genetic variants associated with protein level variation in SCD. Our results provide an opportunity to prioritize novel SCD drug targets that are informed by human genetics.

Authors

Institutions

Publication Details

Journal
PLoS Genetics
Published
2026-11-16
DOI
https://doi.org/10.1371/journal.pgen.1012377
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Proteogenomic analysis of 5,411 plasma proteins in sickle cell disease patients

Ken Sin Lo, Cristian Groza, Pablo Bartolucci, Arnaud Chignon et al.
1 links
PLoS Genetics
Hemoglobinopathies and Related Disorders
article

Proteogenomic analysis of 5,411 plasma proteins in sickle cell disease patients

Ken Sin Lo, Cristian Groza, Pablo Bartolucci, Arnaud Chignon, Guillaume Lettre, Vanessa Bellegarde
article en

Abstract

There are few therapeutic options to treat patients with sickle cell disease (SCD), a blood disorder caused by mutations in the β-globin gene that affects > 7M individuals worldwide. Combining human genetics and high-throughput proteomics can help identify new drug targets. Here, we present results from a proteogenomic analysis of the plasma proteome in SCD patients. We measured the levels of 5,411 plasma proteins and tested their associations with common genetic variation in 343 SCD patients. After conditional analyses, we identified 560 protein quantitative trait loci (pQTL), including 58 (10%) that are novel. Many of these pQTL are not specific to SCD patients and associate with clinically relevant traits in non-SCD African Americans from the Million Veteran Program (e.g., hemoglobin concentration, triglycerides). The effect sizes of the pQTL are largely concordant between SCD and non-SCD individuals, although we found examples (e.g., APOL1, haptoglobin) with evidence of heterogeneity that suggests an interaction between the plasma proteome and the SCD genotype. Finally, we combine pQTL and genome-wide association study results for fetal hemoglobin (HbF) in a Mendelian randomization analysis to prioritize four proteins that may increase HbF production (ENPP5, LBP, PTX3, ZP3). We have combined high-throughput DNA genotyping and plasma proteome profiling to confirm known and identify new genetic variants associated with protein level variation in SCD. Our results provide an opportunity to prioritize novel SCD drug targets that are informed by human genetics.

PLoS GeneticsVol. 22(11)
Université Paris-Est Créteil (FR), Montreal Heart Institute (CA), Université de Montréal (CA)
McGill University, Banting Research Foundation, Canada Research Chairs, Alliance de recherche numérique du Canada, Canadian Institutes of Health Research, Fonds de recherche du Québec – Nature et technologies, Institute of Genetics
Good health and well-being
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon